{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:37Z","timestamp":1792788277032,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300661"],"award-info":[{"award-number":["82300661"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203866"],"award-info":[{"award-number":["82203866"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Outstanding Youth Science Foundation of the Department of Education of Anhui Province","award":["2024AH030020"],"award-info":[{"award-number":["2024AH030020"]}]},{"name":"Natural Science Foundation of Anhui province","award":["2308085QH246"],"award-info":[{"award-number":["2308085QH246"]}]},{"name":"Natural Science Foundation of the Anhui Higher Education Institutions","award":["KJ2021A0205"],"award-info":[{"award-number":["KJ2021A0205"]}]},{"name":"Basic and Clinical cooperative research program of Anhui Medical University","award":["2022xkjT013"],"award-info":[{"award-number":["2022xkjT013"]}],"id":[{"id":"https:\/\/ror.org\/03xb04968","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Scientific Research Foundation of Anhui Medical University","award":["2023xkj002"],"award-info":[{"award-number":["2023xkj002"]}],"id":[{"id":"https:\/\/ror.org\/03xb04968","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly prevalent, yet effective therapies remain limited. Curcumin (Cur), a polyphenol with well-documented metabolic benefits, shows therapeutic promise in MASLD, but its efficacy and underlying mechanisms remain incompletely understood. A meta-analysis of seven clinical studies indicated that Cur supplementation reduced serum aminotransferase levels, supporting its potential clinical benefit. In high-fat diet (HFD)-fed rats, Cur reduced hepatic lipid accumulation and metabolic dysfunction, whereas these effects were markedly weakened in antibiotic-induced pseudo-germ-free rats, indicating microbiota dependence. Fecal microbiota transplantation from Cur-treated donors transferred these metabolic and histological benefits to antibiotic-conditioned recipients. Fecal 16S rRNA sequencing identified\n                    <jats:italic>Clostridium_sensu_stricto_1<\/jats:italic>\n                    (\n                    <jats:italic>C. sensu<\/jats:italic>\n                    ) as a Cur-suppressed, pro-steatotic taxon, and targeted reconstitution of this taxon abolished Cur-mediated protection. Untargeted hepatic metabolomics and liquid chromatography\u2013mass spectrometry identified kynurenine (KYN) as a\n                    <jats:italic>C. sensu<\/jats:italic>\n                    -derived metabolite and showed that Cur reduced hepatic KYN accumulation. Integrated H3K27ac ChIP-seq, bulk RNA-seq, and single-cell analyses pinpointed hepatocyte-enriched\n                    <jats:italic>CEBPB<\/jats:italic>\n                    as a key epigenetically regulated effector. Luciferase reporter assays, ChIP-qPCR, and gain- and loss-of-function experiments showed that KYN activated the aryl hydrocarbon receptor (AHR), increased H3K27ac enrichment at the\n                    <jats:italic>Cebpb<\/jats:italic>\n                    locus, and induced\n                    <jats:italic>Cebpb<\/jats:italic>\n                    transcription.\n                    <jats:italic>CEBPB<\/jats:italic>\n                    knockdown blocked KYN-induced PI3K-AKT activation and lipid accumulation, whereas in vivo KYN supplementation largely reversed Cur-mediated protection. Collectively, this study reveals a novel gut-liver axis in MASLD pathogenesis, demonstrating that Cur alleviates hepatic steatosis by targeting the microbiota-KYN-AHR-H3K27ac-\n                    <jats:italic>Cebpb<\/jats:italic>\n                    epigenetic axis, positioning Cur supplementation and KYN modulation as promising therapeutic strategies for MASLD intervention.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00606-1","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:34:11Z","timestamp":1792143251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Curcumin alleviates metabolic dysfunction-associated steatotic liver disease via gut microbiota-dependent epigenetic alterations"],"prefix":"10.1186","volume":"7","author":[{"given":"Yong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulei","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2302-9837","authenticated-orcid":false,"given":"Yaling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"9","key":"606_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361. https:\/\/doi.org\/10.1016\/S2468-1253(22)00165-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"606_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338. https:\/\/doi.org\/10.1038\/s41575-020-00381-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"606_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/hep.29489","volume":"67","author":"R Vuppalanchi","year":"2018","unstructured":"Vuppalanchi R, Siddiqui MS, Van Natta ML, Neuschwander\u2010Tetri BA, Tonascia JA, Kleiner DE, et al. Performance characteristics of vibration\u2010controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018;67(1):134\u201344. https:\/\/doi.org\/10.1002\/hep.29489.","journal-title":"Hepatology"},{"issue":"5","key":"606_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/08923973.2024.2384911","volume":"46","author":"BS Mendon\u00e7a","year":"2024","unstructured":"Mendon\u00e7a BS, Nascimento LMM, Ferro JNdS, dos Santos Reis MD. The effect of plant-derived polyphenols on the immune system during aging: a systematic review. Immunopharmacol Immunotoxicol. 2024;46(5):604\u201317. https:\/\/doi.org\/10.1080\/08923973.2024.2384911.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"2","key":"606_CR5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00210-024-03455-3","volume":"398","author":"Z Foroutan","year":"2025","unstructured":"Foroutan Z, Cicero AFG, Jamialahmadi T, Sahebkar A. Curcuminoids as natural modulators of necroptosis: therapeutic implications. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(2):1299\u2013304. https:\/\/doi.org\/10.1007\/s00210-024-03455-3.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"606_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/ijms20020395","volume":"20","author":"I Milosevic","year":"2019","unstructured":"Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. Int J Mol Sci. 2019;20(2):395. https:\/\/doi.org\/10.3390\/ijms20020395.","journal-title":"Int J Mol Sci"},{"issue":"1S","key":"606_CR7","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1097\/MEG.0000000000002140","volume":"33","author":"H Ebrahimzadeh Leylabadlo","year":"2021","unstructured":"Ebrahimzadeh Leylabadlo H, Samadi Kafil H, Farajnia S, Shanehbandi D, Yaghoub Moaddab S, Feizabadi MM, et al. Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus. Eur J Gastroenterol Hepatol. 2021;33(1S):e548\u201354. https:\/\/doi.org\/10.1097\/MEG.0000000000002140.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"606_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, B\u00e4ckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19(2):77\u201394. https:\/\/doi.org\/10.1038\/s41579-020-0438-4.","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"606_CR9","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/hep.30652","volume":"73","author":"YE Cho","year":"2021","unstructured":"Cho YE, Kim DK, Seo W, Gao B, Yoo SH, Song BJ. Fructose promotes leaky gut, endotoxemia, and liver fibrosis through ethanol\u2010inducible cytochrome P450\u20102E1\u2013mediated oxidative and nitrative stress. Hepatology. 2021;73(6):2180\u201395. https:\/\/doi.org\/10.1002\/hep.30652.","journal-title":"Hepatology"},{"key":"606_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1086078","volume":"14","author":"L-R Zhu","year":"2023","unstructured":"Zhu L-R, Li S-S, Zheng W-Q, Ni W-J, Cai M, Liu H-P. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy. Front Immunol. 2023;14:1086078. https:\/\/doi.org\/10.3389\/fimmu.2023.1086078.","journal-title":"Front Immunol"},{"issue":"1","key":"606_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","volume":"74","author":"S Ha","year":"2025","unstructured":"Ha S, Wong VW, Zhang X, Yu J. Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma. Gut. 2025;74(1):141\u201352. https:\/\/doi.org\/10.1136\/gutjnl-2024-332398.","journal-title":"Gut"},{"issue":"45","key":"606_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404224","volume":"11","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Shang L, Tang Y, Li Q, Ding L, Wang Y, et al. Genome-wide profiling of H3K27ac identifies TDO2 as a pivotal therapeutic target in metabolic associated steatohepatitis liver disease. Adv Sci (Weinh). 2024;11(45):e2404224. https:\/\/doi.org\/10.1002\/advs.202404224.","journal-title":"Adv Sci (Weinh)"},{"key":"606_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2023.109878","volume":"752","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhao H, Yang Y, Liu Y, Ao C-Y, Zeng J-M, et al. Mechanism by which HDAC3 regulates manganese induced H3K27ac in SH-SY5Y cells and intervention by curcumin. Arch Biochem Biophys. 2024;752:109878. https:\/\/doi.org\/10.1016\/j.abb.2023.109878.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"606_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ajcnut.2024.05.017","volume":"120","author":"Y He","year":"2024","unstructured":"He Y, Chen X, Li Y, Liang Y, Hong T, Yang J, et al. Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial. Am J Clin Nutr. 2024;120(1):66\u201379. https:\/\/doi.org\/10.1016\/j.ajcnut.2024.05.017.","journal-title":"Am J Clin Nutr"},{"issue":"3-4","key":"606_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1024\/0300-9831\/a000629","volume":"91","author":"SR Mirhafez","year":"2021","unstructured":"Mirhafez SR, Rezai A, Dehabeh M, Gh BFNM, Bidkhori M, Sahebkar A, et al. Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease. Int J Vitam Nutr Res. 2021;91(3\u20134):278\u201386. https:\/\/doi.org\/10.1024\/0300-9831\/a000629.","journal-title":"Int J Vitam Nutr Res"},{"key":"606_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-030-64872-5_3","volume-title":"Pharmacological properties of plant-derived natural products and implications for human health","author":"SR Mirhafez","year":"2021","unstructured":"Mirhafez SR, Azimi-Nezhad M, Dehabeh M, Hariri M, Naderan RD, Movahedi A, et al. The effect of curcumin phytosome on the treatment of patients with non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled trial. In: Barreto GE, Sahebkar A, editors., et al., Pharmacological properties of plant-derived natural products and implications for human health. Cham: Springer International Publishing; 2021. p. 25\u201335."},{"key":"606_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102447","volume":"51","author":"M Hariri","year":"2020","unstructured":"Hariri M, Gholami A, Mirhafez SR, Bidkhori M, Sahebkar A. A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled, clinical trial. Complement Ther Med. 2020;51:102447. https:\/\/doi.org\/10.1016\/j.ctim.2020.102447.","journal-title":"Complement Ther Med"},{"issue":"2","key":"606_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.15403\/jgld-179","volume":"28","author":"SR Mirhafez","year":"2019","unstructured":"Mirhafez SR, Farimani AR, Dehhabe M, Bidkhori M, Hariri M, Ghouchani BF, et al. Effect of phytosomal curcumin on circulating levels of adiponectin and leptin in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial. J Gastrointestin Liver Dis. 2019;28(2):183\u20139. https:\/\/doi.org\/10.15403\/jgld-179.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"4","key":"606_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1055\/s-0043-100019","volume":"67","author":"Y Panahi","year":"2017","unstructured":"Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mend\u00eda LE, Sahebkar A. Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug Res (Stuttg). 2017;67(4):244\u201351. https:\/\/doi.org\/10.1055\/s-0043-100019.","journal-title":"Drug Res (Stuttg)"},{"issue":"9","key":"606_CR20","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ptr.5659","volume":"30","author":"S Rahmani","year":"2016","unstructured":"Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al. Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial. Phytother Res. 2016;30(9):1540\u20138. https:\/\/doi.org\/10.1002\/ptr.5659.","journal-title":"Phytother Res"},{"issue":"9","key":"606_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/nu14091828","volume":"14","author":"T Hong","year":"2022","unstructured":"Hong T, Zou J, Jiang X, Yang J, Cao Z, He Y, et al. Curcumin supplementation ameliorates bile cholesterol supersaturation in hamsters by modulating gut microbiota and cholesterol absorption. Nutrients. 2022;14(9):1828. https:\/\/doi.org\/10.3390\/nu14091828.","journal-title":"Nutrients"},{"issue":"572","key":"606_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz2841","volume":"12","author":"O Rom","year":"2020","unstructured":"Rom O, Liu Y, Liu Z, Zhao Y, Wu J, Ghrayeb A, et al. Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome. Sci Transl Med. 2020;12(572):eaaz2841. https:\/\/doi.org\/10.1126\/scitranslmed.aaz2841.","journal-title":"Sci Transl Med"},{"key":"606_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.109103","volume":"109","author":"T Hong","year":"2022","unstructured":"Hong T, Jiang X, Zou J, Yang J, Zhang H, Mai H, et al. Hepatoprotective effect of curcumin against bisphenol A-induced hepatic steatosis via modulating gut microbiota dysbiosis and related gut-liver axis activation in CD-1 mice. J Nutr Biochem. 2022;109:109103. https:\/\/doi.org\/10.1016\/j.jnutbio.2022.109103.","journal-title":"J Nutr Biochem"},{"issue":"11","key":"606_CR24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/metabo13111166","volume":"13","author":"Y Hou","year":"2023","unstructured":"Hou Y, Li J, Ying S. Tryptophan metabolism and gut microbiota: a novel regulatory axis integrating the microbiome, immunity, and cancer. Metabolites. 2023;13(11):1166. https:\/\/doi.org\/10.3390\/metabo13111166.","journal-title":"Metabolites"},{"issue":"50","key":"606_CR25","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","volume":"107","author":"MP Creyghton","year":"2010","unstructured":"Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A. 2010;107(50):21931\u20136. https:\/\/doi.org\/10.1073\/pnas.1016071107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7917","key":"606_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41586-022-04877-w","volume":"607","author":"DT Bergman","year":"2022","unstructured":"Bergman DT, Jones TR, Liu V, Ray J, Jagoda E, Siraj L, et al. Compatibility rules of human enhancer and promoter sequences. Nature. 2022;607(7917):176\u201384. https:\/\/doi.org\/10.1038\/s41586-022-04877-w.","journal-title":"Nature"},{"issue":"2","key":"606_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1074\/jbc.R114.619957","volume":"290","author":"L Guo","year":"2015","unstructured":"Guo L, Li X, Tang Q-Q. Transcriptional regulation of adipocyte differentiation: a central role for CCAAT\/enhancer-binding protein (C\/EBP) \u03b2. J Biol Chem. 2015;290(2):755\u201361. https:\/\/doi.org\/10.1074\/jbc.R114.619957.","journal-title":"J Biol Chem"},{"issue":"21","key":"606_CR28","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1158\/0008-5472.CAN-15-2011","volume":"75","author":"NC D'Amato","year":"2015","unstructured":"D\u2019Amato NC, Rogers TJ, Gordon MA, Greene LI, Cochrane DR, Spoelstra NS, et al. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. Cancer Res. 2015;75(21):4651\u201364. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2011.","journal-title":"Cancer Res"},{"issue":"12","key":"606_CR29","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1111\/bph.15787","volume":"179","author":"Y Chang","year":"2022","unstructured":"Chang Y, Han P, Wang Y, Jia C, Zhang B, Zhao Y, et al. Tryptophan 2,3-dioxygenase 2 plays a key role in regulating the activation of fibroblast-like synoviocytes in autoimmune arthritis. Br J Pharmacol. 2022;179(12):3024\u201342. https:\/\/doi.org\/10.1111\/bph.15787.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"606_CR30","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.7150\/ijbs.92337","volume":"20","author":"YC Wu","year":"2024","unstructured":"Wu YC, Yan Q, Yue SQ, Pan LX, Yang DS, Tao LS, et al. NUP85 alleviates lipid metabolism and inflammation by regulating PI3K\/AKT signaling pathway in nonalcoholic fatty liver disease. Int J Biol Sci. 2024;20(6):2219\u201335. https:\/\/doi.org\/10.7150\/ijbs.92337.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"606_CR31","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41467-023-37142-3","volume":"14","author":"Q Ye","year":"2023","unstructured":"Ye Q, Liu Y, Zhang G, Deng H, Wang X, Tuo L, et al. Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K\/AKT\/PDGF axis activation in male mice. Nat Commun. 2023;14(1):1402. https:\/\/doi.org\/10.1038\/s41467-023-37142-3.","journal-title":"Nat Commun"},{"key":"606_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115279","volume":"165","author":"Y He","year":"2023","unstructured":"He Y, Wang H, Lin S, Chen T, Chang D, Sun Y, et al. Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K\/AKT\/mTOR and HIF-1\/VEGF cascade. Biomed Pharmacother. 2023;165:115279. https:\/\/doi.org\/10.1016\/j.biopha.2023.115279.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"606_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/oby.23065","volume":"29","author":"IY Rojas","year":"2021","unstructured":"Rojas IY, Moyer BJ, Ringelberg CS, Wilkins OM, Pooler DB, Ness DB, et al. Kynurenine-induced aryl hydrocarbon receptor signaling in mice causes body mass gain, liver steatosis, and hyperglycemia. Obesity (Silver Spring). 2021;29(2):337\u201349. https:\/\/doi.org\/10.1002\/oby.23065.","journal-title":"Obesity (Silver Spring)"},{"key":"606_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1442282","volume":"16","author":"W Zheng","year":"2025","unstructured":"Zheng W, Liu M, Lv X, He C, Yin J, Ma J. Ahr governs lipid metabolism: the role of gut microbiota. Front Microbiol. 2025;16:1442282. https:\/\/doi.org\/10.3389\/fmicb.2025.1442282.","journal-title":"Front Microbiol"},{"issue":"1","key":"606_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19(1):60\u201378. https:\/\/doi.org\/10.1038\/s41575-021-00523-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"606_CR36","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/nu11102376","volume":"11","author":"A Giordano","year":"2019","unstructured":"Giordano A, Tommonaro G. Curcumin and cancer. Nutrients. 2019;11(10):2376. https:\/\/doi.org\/10.3390\/nu11102376.","journal-title":"Nutrients"},{"key":"606_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111119","volume":"134","author":"A Zia","year":"2021","unstructured":"Zia A, Farkhondeh T, Pourbagher-Shahri AM, Samarghandian S. The role of curcumin in aging and senescence: molecular mechanisms. Biomed Pharmacother. 2021;134:111119. https:\/\/doi.org\/10.1016\/j.biopha.2020.111119.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"606_CR38","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/j.apsb.2021.12.014","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, Zhu R, Jiang H, Yin Q, Gu J, Chen J, et al. Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB\u2013P300\u2013BRD4 axis. Acta Pharm Sin B. 2022;12(5):2280\u201399. https:\/\/doi.org\/10.1016\/j.apsb.2021.12.014.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"606_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043323","volume":"24","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Luo Y, Wang L, Zhang K, Peng J, Fan G. Therapeutic effect of curcumin on metabolic diseases: evidence from clinical studies. Int J Mol Sci. 2023;24(4):3323. https:\/\/doi.org\/10.3390\/ijms24043323.","journal-title":"Int J Mol Sci"},{"key":"606_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155241","volume":"123","author":"X Li","year":"2024","unstructured":"Li X, Chen W, Ren J, Gao X, Zhao Y, Song T, et al. Effects of curcumin on non-alcoholic fatty liver disease: a scientific metrogy study. Phytomedicine. 2024;123:155241. https:\/\/doi.org\/10.1016\/j.phymed.2023.155241.","journal-title":"Phytomedicine"},{"issue":"6","key":"606_CR41","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/10408398.2018.1552244","volume":"60","author":"SS Patel","year":"2020","unstructured":"Patel SS, Acharya A, Ray RS, Agrawal R, Raghuwanshi R, Jain P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit Rev Food Sci Nutr. 2020;60(6):887\u2013939. https:\/\/doi.org\/10.1080\/10408398.2018.1552244.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"606_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.intimp.2017.01.016","volume":"44","author":"R Afrin","year":"2017","unstructured":"Afrin R, Arumugam S, Rahman A, Wahed MII, Karuppagounder V, Harima M, et al. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-\u03baB translocation. Int Immunopharmacol. 2017;44:174\u201382. https:\/\/doi.org\/10.1016\/j.intimp.2017.01.016.","journal-title":"Int Immunopharmacol"},{"key":"606_CR43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.biopha.2018.05.135","volume":"105","author":"C Yan","year":"2018","unstructured":"Yan C, Zhang Y, Zhang X, Aa J, Wang G, Xie Y. Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice. Biomed Pharmacother. 2018;105:274\u201381. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.135.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"606_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/labinvest.2009.112","volume":"90","author":"F Vizzutti","year":"2010","unstructured":"Vizzutti F, Provenzano A, Galastri S, Milani S, Delogu W, Novo E, et al. Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Lab Invest. 2010;90(1):104\u201315. https:\/\/doi.org\/10.1038\/labinvest.2009.112.","journal-title":"Lab Invest"},{"issue":"2","key":"606_CR45","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1039\/c7fo01242j","volume":"9","author":"T Tsuda","year":"2018","unstructured":"Tsuda T. Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives. Food Funct. 2018;9(2):705\u201314. https:\/\/doi.org\/10.1039\/c7fo01242j.","journal-title":"Food Funct"},{"issue":"18","key":"606_CR46","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1080\/10408398.2018.1478388","volume":"59","author":"L Shen","year":"2019","unstructured":"Shen L, Ji HF. Bidirectional interactions between dietary curcumin and gut microbiota. Crit Rev Food Sci Nutr. 2019;59(18):2896\u2013902. https:\/\/doi.org\/10.1080\/10408398.2018.1478388.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"24","key":"606_CR47","doi-asserted-by":"publisher","first-page":"8822","DOI":"10.1080\/10408398.2023.2204349","volume":"64","author":"T Qin","year":"2024","unstructured":"Qin T, Chen X, Meng J, Guo Q, Xu S, Hou S, et al. The role of curcumin in the liver-gut system diseases: from mechanisms to clinical therapeutic perspective. Crit Rev Food Sci Nutr. 2024;64(24):8822\u201351. https:\/\/doi.org\/10.1080\/10408398.2023.2204349.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"606_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40104-021-00573-3","volume":"12","author":"Q Shang","year":"2021","unstructured":"Shang Q, Liu S, Liu H, Mahfuz S, Piao X. Impact of sugar beet pulp and wheat bran on serum biochemical profile, inflammatory responses and gut microbiota in sows during late gestation and lactation. J Anim Sci Biotechnol. 2021;12(1):54. https:\/\/doi.org\/10.1186\/s40104-021-00573-3.","journal-title":"J Anim Sci Biotechnol"},{"issue":"5","key":"606_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205784","volume":"14","author":"W-Y Yang","year":"2019","unstructured":"Yang W-Y, Lee Y, Lu H, Chou C-H, Wang C. Analysis of gut microbiota and the effect of lauric acid against necrotic enteritis in Clostridium perfringens and Eimeria side-by-side challenge model. PLoS ONE. 2019;14(5):e0205784. https:\/\/doi.org\/10.1371\/journal.pone.0205784.","journal-title":"PLoS ONE"},{"issue":"21","key":"606_CR50","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.3748\/wjg.v27.i21.2834","volume":"27","author":"X Wen","year":"2021","unstructured":"Wen X, Wang HG, Zhang MN, Zhang MH, Wang H, Yang XZ. Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation. World J Gastroenterol. 2021;27(21):2834\u201349. https:\/\/doi.org\/10.3748\/wjg.v27.i21.2834.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"606_CR51","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000310","volume":"8","author":"Q Long","year":"2024","unstructured":"Long Q, Luo F, Li B, Li Z, Guo Z, Chen Z, et al. Gut microbiota and metabolic biomarkers in metabolic dysfunction\u2013associated steatotic liver disease. Hepatol Commun. 2024;8(3):e0310. https:\/\/doi.org\/10.1097\/HC9.0000000000000310.","journal-title":"Hepatol Commun"},{"issue":"10","key":"606_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2025.100783","volume":"4","author":"X Zhang","year":"2025","unstructured":"Zhang X, Chen J, van Kleef LA, Medina-Gomez C, van Meurs JBJ, Ikram MA, et al. Integrating gut microbiome and metabolome to gain insight into metabolic dysfunction-associated steatotic liver disease. Gastro Hep Adv. 2025;4(10):100783. https:\/\/doi.org\/10.1016\/j.gastha.2025.100783.","journal-title":"Gastro Hep Adv"},{"issue":"1","key":"606_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13099-026-00798-5","volume":"18","author":"JW Hahn","year":"2026","unstructured":"Hahn JW, Lim JG, Lee KJ, Moon JS, Kim TH, Son Y, et al. Clinical and microbial correlates of response to lifestyle intervention in pediatric metabolic dysfunction-associated steatotic liver disease. Gut Pathog. 2026;18(1):6. https:\/\/doi.org\/10.1186\/s13099-026-00798-5.","journal-title":"Gut Pathog"},{"issue":"3","key":"606_CR54","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/ijms26030968","volume":"26","author":"Q Tan","year":"2025","unstructured":"Tan Q, Deng S, Xiong L. Role of kynurenine and its derivatives in liver diseases: recent advances and future clinical perspectives. Int J Mol Sci. 2025;26(3):968. https:\/\/doi.org\/10.3390\/ijms26030968.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"606_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14279","volume":"54","author":"C Arto","year":"2024","unstructured":"Arto C, Rusu EC, Clavero-Mestres H, Barrientos-Riosalido A, Bertran L, Mahmoudian R, et al. Metabolic profiling of tryptophan pathways: implications for obesity and metabolic dysfunction-associated steatotic liver disease. Eur J Clin Invest. 2024;54(11):e14279. https:\/\/doi.org\/10.1111\/eci.14279.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"606_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01606-x","volume":"11","author":"P Sun","year":"2023","unstructured":"Sun P, Wang M, Liu Y-X, Li L, Chai X, Zheng W, et al. High-fat diet-disturbed gut microbiota-colonocyte interactions contribute to dysregulating peripheral tryptophan-kynurenine metabolism. Microbiome. 2023;11(1):154. https:\/\/doi.org\/10.1186\/s40168-023-01606-x.","journal-title":"Microbiome"},{"issue":"6","key":"606_CR57","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):716\u201324. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003.","journal-title":"Cell Host Microbe"},{"issue":"6349","key":"606_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9794","volume":"357","author":"I Cervenka","year":"2017","unstructured":"Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health. Science. 2017;357(6349):eaaf9794. https:\/\/doi.org\/10.1126\/science.aaf9794.","journal-title":"Science"},{"issue":"6","key":"606_CR59","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 2010;185(6):3190\u20138. https:\/\/doi.org\/10.4049\/jimmunol.0903670.","journal-title":"J Immunol"},{"key":"606_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2012.03.026","volume":"1455","author":"X-D Wang","year":"2012","unstructured":"Wang X-D, Notarangelo FM, Wang J-Z, Schwarcz R. Kynurenic acid and 3-hydroxykynurenine production from d-kynurenine in mice. Brain Res. 2012;1455:1\u20139. https:\/\/doi.org\/10.1016\/j.brainres.2012.03.026.","journal-title":"Brain Res"},{"key":"606_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuropharm.2017.04.023","volume":"121","author":"DM Bortz","year":"2017","unstructured":"Bortz DM, Wu HQ, Schwarcz R, Bruno JP. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex. Neuropharmacology. 2017;121:69\u201378. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.023.","journal-title":"Neuropharmacology"},{"issue":"1","key":"606_CR62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41538-022-00156-0","volume":"6","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gu Y, Jiang J, Cui X, Cheng S, Liu L, et al. Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism. NPJ Sci Food. 2022;6(1):38. https:\/\/doi.org\/10.1038\/s41538-022-00156-0.","journal-title":"NPJ Sci Food"},{"issue":"1","key":"606_CR63","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1038\/s41467-022-34671-1","volume":"13","author":"Y Lei","year":"2022","unstructured":"Lei Y, Tang L, Chen Q, Wu L, He W, Tu D, et al. Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism. Nat Commun. 2022;13(1):6862. https:\/\/doi.org\/10.1038\/s41467-022-34671-1.","journal-title":"Nat Commun"},{"issue":"6","key":"606_CR64","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"D Kleiner","year":"2005","unstructured":"Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease\u2020. Hepatology. 2005;41(6):1313\u201321. https:\/\/doi.org\/10.1002\/hep.20701.","journal-title":"Hepatology"},{"issue":"Database issue","key":"606_CR65","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590\u20136. https:\/\/doi.org\/10.1093\/nar\/gks1219.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"606_CR66","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137. https:\/\/doi.org\/10.1038\/s41587-019-0209-9.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"606_CR67","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/j.1654-1103.2003.tb02228.x","volume":"14","author":"P Dixon","year":"2003","unstructured":"Dixon P. VEGAN, a package of R functions for community ecology. J Veg Sci. 2003;14(6):927\u201330. https:\/\/doi.org\/10.1111\/j.1654-1103.2003.tb02228.x.","journal-title":"J Veg Sci"},{"issue":"6","key":"606_CR68","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60.","journal-title":"Genome Biol"},{"issue":"9","key":"606_CR69","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MGI Langille","year":"2013","unstructured":"Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814\u201321. https:\/\/doi.org\/10.1038\/nbt.2676.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"606_CR70","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3390\/microorganisms12091902","volume":"12","author":"S Lin","year":"2024","unstructured":"Lin S, Liang Y, Geng J, Yan Y, Ding R, He M. Gestational interrelationships among gut\u2013metabolism\u2013transcriptome in regulating early embryo implantation and placental development in mice. Microorganisms. 2024;12(9):1902. https:\/\/doi.org\/10.3390\/microorganisms12091902.","journal-title":"Microorganisms"},{"issue":"1","key":"606_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.24272\/j.issn.2095-8137.2023.022","volume":"45","author":"Y-L Zhu","year":"2024","unstructured":"Zhu Y-L, Meng L-L, Ma J-H, Yuan X, Chen S-W, Yi X-R, et al. Loss of LBP triggers lipid metabolic disorder through H3K27 acetylation-mediated C\/EBP\u03b2-SCD activation in non-alcoholic fatty liver disease. Zool Res. 2024;45(1):79\u201394. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2023.022.","journal-title":"Zool Res"},{"issue":"12","key":"606_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"7837","key":"606_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41586-020-2962-9","volume":"588","author":"H Yang","year":"2020","unstructured":"Yang H, Luan Y, Liu T, Lee HJ, Fang L, Wang Y, et al. A map of cis-regulatory elements and 3D genome structures in zebrafish. Nature. 2020;588(7837):337\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2962-9.","journal-title":"Nature"},{"issue":"23","key":"606_CR74","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.2217\/epi-2022-0362","volume":"14","author":"J Ma","year":"2022","unstructured":"Ma J, You D, Chen S, Fang N, Yi X, Wang Y, et al. Epigenetic association study uncovered H3K27 acetylation enhancers and dysregulated genes in high-fat-diet-induced nonalcoholic fatty liver disease in rats. Epigenomics. 2022;14(23):1523\u201340. https:\/\/doi.org\/10.2217\/epi-2022-0362.","journal-title":"Epigenomics"},{"issue":"1","key":"606_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29018-9","volume":"13","author":"M Wu","year":"2022","unstructured":"Wu M, Zhang X, Zhang W, Chiou YS, Qian W, Liu X, et al. Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis. Nat Commun. 2022;13(1):1371. https:\/\/doi.org\/10.1038\/s41467-022-29018-9.","journal-title":"Nat Commun"},{"issue":"5","key":"606_CR76","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L, Han Y, He Q. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"606_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102322","volume":"52","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen C, Chen J, Sang T, Peng H, Lin X, et al. Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. Redox Biol. 2022;52:102322. https:\/\/doi.org\/10.1016\/j.redox.2022.102322.","journal-title":"Redox Biol"},{"key":"606_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.643394","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Sun Y, Ding L, Shi W, Ding K, Zhu Y. Long non-coding RNA LINC00467 correlates to poor prognosis and aggressiveness of breast cancer. Front Oncol. 2021;11:643394. https:\/\/doi.org\/10.3389\/fonc.2021.643394.","journal-title":"Front Oncol"},{"key":"606_CR79","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2020;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00606-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00606-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00606-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:34:12Z","timestamp":1792143252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00606-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00606-1","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures in this study strictly followed international, national, and institutional guidelines for the ethical care and use of animals. Animal collection and experimental protocols complied with Chinese regulations and were conducted in accordance with the guidelines of the Laboratory Animal Center at Anhui Medical University (Hefei, China; Approval No. LLSC20251829).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"214"}}